February 17, 2022

New UC research discovered a unique class of medications that act as blood thinners by inhibiting an enzyme in the genes of tick saliva. The research focused on novel direct thrombin inhibitors (DTI) from tick salivary transcriptomes, or messenger RNA molecules expressed by an organism. The result is the development of new anticoagulant medications that can be used to treat patients with a variety of coronary issues, including heart attacks. The study was published in Nature Communication.

November 2, 2022

A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.

November 17, 2022

According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.

August 10, 2022

University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.

September 6, 2022

Benjamin Kinnear, MD, has been selected as a Visiting Scholar by the American Board of Medical Specialties.

September 27, 2022

Cincinnati.com interviewed some local experts about the upcoming flu season, including Jennifer Forrester, MD, of the Division of Infectious Diseases at the UC College of Medicine.

March 29, 2023

University of Cincinnati research on the steroid dexamethasone's effect on immune cells and benefit to severe COVID-19 patients was recently published in Frontiers in Immunology.

April 25, 2023

An international multicenter study that was conducted at the University of Cincinnati was stopped early after research demonstrated that a daily statin medication reduced the risk of cardiovascular disease among people living with HIV.

January 18, 2023

Research from the University of Cincinnati shows people who wear tefillin, leather bands used in a Jewish religious practice which involves the tight wrapping of an arm with the bands, may receive cardiovascular health benefits. The study suggests those benefits are the result of ischemic or reduced blood flow preconditioning which produces protection from the damage caused by heart attacks.

January 4, 2023

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis. The research was published in the Annals of Internal Medicine.